Psychedelic-inspired medicine to treat mental illness
Dr Sam Banister CSO
Joshua Ismin CEO
Get in Contact
What does success look like to you?
The need for more efficacious mental health treatment is on the rise as patents on the top SSRI antidepressants continue to expire, leading incumbent pharmaceutical companies to increasingly explore psychedelics as mental illness treatments. It’s therefore no surprise that over $1B USD of private investment has flowed into the sector in the last two years.
Psylo is building a robust pipeline of psychedelic inspired NCEs. Success for us is the identification of a clinical candidate, and the successful preparation of the necessary data package to support an IND filing.